Eli Lilly vs Roche: Revenue Comparison
Eli Lilly (LLY) and Roche (RHHBY) are peers in GLP-1. Eli Lilly reported revenue of $19.8B as of Q1 2026, compared with $34.3B for Roche. Roche leads on revenue.
Eli Lilly's gross margin is 81.9% versus 71.7% for Roche. Eli Lilly's net margin is 37.4% versus 17.9% for Roche.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Eli Lilly 19.799, Roche 17.1305.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Roche.| Metric | Eli Lilly | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $19.80B | $34.26B |
| Cost of Revenue | $3.58B | $9.68B |
| Gross Profit | $16.22B | $24.58B |
| Operating Income | $8.85B | $7.96B |
| Net Income | $7.40B | $6.13B |
| R&D Expense | $3.51B | $7.48B |
| Earnings Per Share | $8.26 | $0.95 |
| Gross Margin | 81.9% | 71.7% |
| Operating Margin | 44.7% | 23.2% |
| Net Profit Margin | 37.4% | 17.9% |
| Free Cash Flow | $3.01B | $10.67B |
| Cumulative Free Cash Flow | $101.90B | $299.34B |
| Operating Cash Flow | $5.33B | $13.12B |
| Cash & Equivalents | $5.14B | $6.32B |